On the latest episode of The Midnight Sentinel, I was joined by Dr. Carrie Madej. It was actually quite challenging to isolate an individual topic to highlight in this article because she drops multiple bombshells in the hour-long interview. I chose the monoclonal antibodies topic because it may be the most pressing for those who are currently experiencing or may soon be experiencing the rapidly spreading Omicron variant.
“Even in the freedom movement, the ‘anti-vaxxers,’ people are against getting these injections or genetic modification devices, really, but then I see those same people run to get the monoclonal antibodies and I think, ‘Oh, you just have no idea,'” she said.
“There’s a problem also with the human-mouse antibody cell line,” she continued. “It has a trade name called VelocImmune. So, I knew this, I recognized this from years ago when I had a very big practice here in Georgia. I took different cases, complicated, and of course I got cancer patients. Well, many of them were breast cancer patients that were put on a newer chemotherapy agent immunotherapy.
“And they use this same mouse-human line. It’s called VelocImmune, okay. So they took that line and they put this in this chemo-agent. At first, the people looked great. These women were doing wonderfully. ‘I feel good. My tumor shrank.’
“And then what happened within one to three years? Sometimes five but usually one to three years there was an allergic reaction, they called it, and a woman would come back loaded with cancer. All the organs looked like they had melted together. I couldn’t, nor could the radiologist, tell one organ from another. So, it was a fulminant, terrible reaction. This was a failure.
“They’re going to use the same mouse line on people right now. This is horrifying because, although people are only getting one or two of these doses, not many, this can’t be good.”
No, it definitely cannot be good. READ MORE…
